Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
20.98
-1.79 (-7.86%)
May 12, 2025, 3:33 PM - Market open
Palvella Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$44.43
Upside
+111.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +81.12% | Apr 30, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +138.32% | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +81.12% | Apr 1, 2025 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +114.49% | Mar 26, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +114.49% | Mar 25, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +138.32% | Mar 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $39 | Strong Buy | Maintains | $39 | +85.89% | Feb 26, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +85.89% | Feb 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +81.12% | Feb 11, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +109.72% | Feb 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +81.12% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +81.12% | Jan 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +81.12% | Dec 26, 2024 |